Ascentage Pharma AAPG
$11.97 −$0.47 (-3.78%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $11.97 0.00%
Open$12.26
Prev close$12.44
Day range$11.97 – $12.26
Volume5,039
Market cap$1.12B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: ANNUAL, ended Dec 2025 · reported in CNY
RevenueCN¥574.12M-41.5% YoY
Operating profit-CN¥1.20B-223.9% YoY
Net profit-CN¥1.24B-206.4% YoY
Diluted EPS-CN¥13.96-160.4% YoY
Annual revenue
Profitability & balance sheet
Gross margin93.9%
Operating margin-216.7%
Net margin-228.5%
Return on equity-240.3%
Return on assets-46.7%
Return on invested capital-59.4%
Current ratio1.22
Liabilities / assets82.5%
Cash & investmentsCN¥1.90B
Total debtCN¥2.08B
Net cash (debt)-CN¥189.36M
Where the revenue comes from
Quarter 2025/FY
By business line
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Balance sheet
| Line item | 2026 Q2 (CNY) |
2025 ANNUAL (CNY) |
2025 Q4 (CNY) |
2025 Q2 (CNY) |
2024 ANNUAL (CNY) |
|---|---|---|---|---|---|
| Total Assets | CN¥3.24B | CN¥3.96B | CN¥3.96B | CN¥3.05B | CN¥2.62B |
| Total Current Assets | CN¥2.29B | CN¥2.94B | CN¥2.94B | CN¥1.91B | CN¥1.47B |
| Cash and Cash Equivalents & Short-Term Investments | CN¥1.90B | CN¥2.46B | CN¥2.46B | CN¥1.66B | CN¥1.24B |
| -Cash and Cash Equivalents | CN¥1.90B | CN¥2.46B | CN¥2.46B | CN¥1.66B | CN¥1.24B |
| Receivables | CN¥333.38M | CN¥301.14M | CN¥301.14M | CN¥238.68M | CN¥99.07M |
| -Accounts Receivable | CN¥156.40M | CN¥252.94M | CN¥252.94M | CN¥78.36M | CN¥83.14M |
| -Other Receivables | CN¥176.99M | CN¥1.46M | CN¥1.46M | CN¥160.31M | CN¥6.14M |
| Inventory | CN¥64.30M | CN¥28.62M | CN¥28.62M | CN¥8.59M | CN¥6.60M |
| Total Non-Current Assets | CN¥947.44M | CN¥1.02B | CN¥1.02B | CN¥1.14B | CN¥1.14B |
| Net PPE | CN¥800.43M | CN¥829.25M | CN¥829.25M | CN¥871.96M | CN¥905.86M |
| -Gross PPE | CN¥800.43M | CN¥1.12B | CN¥1.12B | CN¥871.96M | CN¥1.13B |
| Investments and Advances | CN¥40.01M | CN¥37.03M | CN¥37.03M | CN¥37.34M | CN¥33.86M |
| -Long Term Equity Investment | CN¥33.01M | CN¥33.03M | CN¥33.03M | CN¥32.72M | CN¥32.72M |
| Goodwill and Other Intangible Assets | CN¥62.26M | CN¥90.63M | CN¥90.63M | CN¥95.69M | CN¥100.69M |
| -Goodwill | CN¥24.69M | CN¥24.69M | CN¥24.69M | CN¥24.69M | CN¥24.69M |
| -Other Intangible Assets | CN¥37.57M | CN¥65.94M | CN¥65.94M | CN¥70.99M | CN¥76.00M |
| Non-Current Deferred Assets | CN¥18.38M | CN¥61.81M | CN¥61.81M | CN¥33.39M | CN¥74.77M |
| Other Non-Current Assets | CN¥26.36M | – | – | CN¥99.06M | – |
| Total Liabilities | CN¥2.67B | CN¥2.63B | CN¥2.63B | CN¥2.37B | CN¥2.34B |
| Total Current Liabilities | CN¥1.88B | CN¥1.64B | CN¥1.64B | CN¥1.24B | CN¥1.17B |
| Payables | CN¥338.84M | CN¥234.58M | CN¥234.58M | CN¥368.03M | CN¥251.61M |
| -Accounts Payable | CN¥106.91M | CN¥106.74M | CN¥106.74M | CN¥118.68M | CN¥91.97M |
| -Other Payable | CN¥231.93M | CN¥114.14M | CN¥114.14M | CN¥249.36M | CN¥150.02M |
| Short-Term Debt and Capital Lease Obligation | CN¥1.48B | CN¥1.22B | CN¥1.22B | CN¥833.78M | CN¥779.06M |
| -Current Debt | CN¥1.47B | CN¥1.22B | CN¥1.22B | CN¥833.78M | CN¥769.62M |
| -Current Capital Lease Obligation | CN¥9.62M | CN¥7.28M | CN¥7.28M | – | CN¥9.44M |
| Current Deferred Liabilities | CN¥69.54M | CN¥60.09M | CN¥60.09M | CN¥37.49M | CN¥54.09M |
| Total Non-Current Liabilities | CN¥791.36M | CN¥985.99M | CN¥985.99M | CN¥1.13B | CN¥1.18B |
| Long Term Debt and Capital Lease Obligation | CN¥619.45M | CN¥757.24M | CN¥757.24M | CN¥882.38M | CN¥889.44M |
| -Long Term Debt | CN¥605.34M | CN¥742.33M | CN¥742.33M | CN¥882.38M | CN¥868.64M |
| -Long Term Capital Lease Obligation | CN¥14.11M | CN¥14.91M | CN¥14.91M | – | CN¥20.79M |
| Non-Current Deferred Liabilities | CN¥164.75M | CN¥216.72M | CN¥216.72M | CN¥236.13M | CN¥281.33M |
| Other Non-Current Liabilities | CN¥7.16M | CN¥12.03M | CN¥12.03M | CN¥12.42M | CN¥6.27M |
| Total Equity | CN¥565.83M | CN¥1.33B | CN¥1.33B | CN¥675.91M | CN¥274.16M |
| Stockholders' Equity | CN¥556.39M | CN¥1.32B | CN¥1.32B | CN¥666.00M | CN¥264.19M |
| Capital Stock | CN¥256,000.00 | CN¥256,000.00 | CN¥256,000.00 | CN¥239,000.00 | CN¥214,000.00 |
| -Common Stock | CN¥256,000.00 | CN¥256,000.00 | CN¥256,000.00 | CN¥239,000.00 | CN¥214,000.00 |
| Additional Paid-In Capital | CN¥8.93B | CN¥8.92B | CN¥8.92B | CN¥7.55B | CN¥6.55B |
| Retained Earnings | -CN¥7.83B | -CN¥7.01B | -CN¥7.01B | -CN¥6.36B | -CN¥5.77B |
| Less: Treasury Stock | -CN¥16.36M | -CN¥2.96M | -CN¥2.96M | -CN¥2.96M | -CN¥8,000.00 |
| Gains/Losses Not Affecting Retained Earnings | -CN¥524.19M | -CN¥576.36M | -CN¥576.36M | -CN¥516.07M | -CN¥510.59M |
| Minority Interests | CN¥9.45M | CN¥9.75M | CN¥9.75M | CN¥9.91M | CN¥9.97M |
| -Taxes Receivable | – | CN¥46.75M | CN¥46.75M | – | CN¥9.79M |
| Prepaid Assets | – | CN¥144.33M | CN¥144.33M | – | CN¥107.28M |
| Restricted Cash | – | CN¥5.69M | CN¥5.69M | – | CN¥24.63M |
| -Accumulated Depreciation | – | -CN¥287.03M | -CN¥287.03M | – | -CN¥221.44M |
| Non-Current Prepaid Assets | – | CN¥690,000.00 | CN¥690,000.00 | – | CN¥2.44M |
| -Total Tax Payable | – | CN¥13.70M | CN¥13.70M | – | CN¥9.63M |
| Current Accrued Expenses | – | CN¥124.25M | CN¥124.25M | – | CN¥81.86M |
| Other Current Liabilities | – | CN¥1.97M | CN¥1.97M | – | – |
| Non Current Accounts Receivables | – | – | – | – | CN¥26.03M |
Income statement
| Line item | 2025 ANNUAL (CNY) |
2024 ANNUAL (CNY) |
2023 ANNUAL (CNY) |
2022 ANNUAL (CNY) |
2021 ANNUAL (CNY) |
|---|---|---|---|---|---|
| Total Revenue as Reported | CN¥574.12M | CN¥980.65M | CN¥221.98M | CN¥209.71M | CN¥27.91M |
| Total Operating Revenue | CN¥574.12M | CN¥980.65M | CN¥221.98M | CN¥209.71M | CN¥27.91M |
| Cost of Revenue | CN¥48.94M | CN¥29.09M | CN¥30.54M | CN¥22.00M | CN¥3.33M |
| Gross Profit | CN¥525.18M | CN¥951.57M | CN¥191.44M | CN¥187.71M | CN¥24.58M |
| Operating Expense | CN¥1.72B | CN¥1.32B | CN¥1.06B | CN¥1.04B | CN¥894.42M |
| Selling and Admin Expenses | CN¥599.92M | CN¥383.12M | CN¥376.46M | CN¥328.02M | CN¥191.26M |
| -Selling & Marketing Expense | CN¥353.64M | CN¥196.00M | CN¥195.39M | CN¥157.42M | CN¥47.75M |
| -General & Admin Expense | CN¥246.28M | CN¥187.13M | CN¥181.08M | CN¥170.60M | CN¥143.51M |
| Research & Development | CN¥1.14B | CN¥947.25M | CN¥706.97M | CN¥743.10M | CN¥766.49M |
| Other Operating Expenses | -CN¥14.50M | -CN¥9.07M | -CN¥19.36M | -CN¥33.60M | -CN¥63.34M |
| Operating Profit | -CN¥1.20B | -CN¥369.73M | -CN¥872.64M | -CN¥849.81M | -CN¥869.84M |
| Net Non-Operating Interest Income (Expense) | CN¥28.06M | -CN¥26.62M | -CN¥63.65M | -CN¥43.06M | -CN¥9.63M |
| Non-Operating Interest Income | CN¥82.13M | CN¥37.84M | CN¥32.41M | CN¥9.73M | CN¥7.11M |
| Non-Operating Interest Expense | CN¥54.07M | CN¥64.46M | CN¥96.06M | CN¥52.79M | CN¥16.73M |
| Other Income (Expense) | -CN¥66.41M | CN¥1.09M | CN¥3.42M | CN¥5.70M | CN¥47.21M |
| Gain on Sale of Security | -CN¥11.30M | CN¥5.86M | CN¥3.74M | CN¥6.97M | CN¥70.62M |
| Earnings from Equity Interest | CN¥314,000.00 | -CN¥281,000.00 | CN¥1.08M | -CN¥278,000.00 | CN¥0.00 |
| Special Income (Charges) | -CN¥18,000.00 | -CN¥50,000.00 | CN¥4,000.00 | CN¥2.07M | -CN¥34,000.00 |
| -Gain on Sale of Property/Plant/Equipment | -CN¥18,000.00 | -CN¥50,000.00 | CN¥4,000.00 | CN¥2.07M | -CN¥34,000.00 |
| Other Non-Operating Income (Expenses) | -CN¥55.41M | -CN¥4.44M | -CN¥1.40M | -CN¥3.06M | -CN¥23.38M |
| Pretax Profit | -CN¥1.24B | -CN¥395.26M | -CN¥932.86M | -CN¥887.17M | -CN¥832.25M |
| Tax | CN¥6.94M | CN¥10.43M | -CN¥7.15M | -CN¥4.25M | -CN¥49.83M |
| Net Profit | -CN¥1.24B | -CN¥405.68M | -CN¥925.71M | -CN¥882.92M | -CN¥782.42M |
| Profit from Continuing Operations | -CN¥1.24B | -CN¥405.68M | -CN¥925.71M | -CN¥882.92M | -CN¥782.42M |
| Minority Interests | -CN¥218,000.00 | -CN¥247,000.00 | -CN¥75,000.00 | CN¥0.00 | – |
| Net Income to Parent Company | -CN¥1.24B | -CN¥405.43M | -CN¥925.64M | -CN¥882.92M | -CN¥782.42M |
| Net Income to Common Stockholders | -CN¥1.24B | -CN¥405.43M | -CN¥925.64M | -CN¥882.92M | -CN¥782.42M |
| Basic EPS | -CN¥13.96 | -CN¥5.36 | -CN¥13.12 | -CN¥13.40 | -CN¥12.28 |
| Diluted EPS | -CN¥13.96 | -CN¥5.36 | -CN¥13.12 | -CN¥13.40 | -CN¥12.28 |
Cash flow
| Line item | 2025 ANNUAL (CNY) |
2024 ANNUAL (CNY) |
2023 ANNUAL (CNY) |
2022 ANNUAL (CNY) |
2021 ANNUAL (CNY) |
|---|---|---|---|---|---|
| Operating Cash Flow | -CN¥1.17B | -CN¥111.36M | -CN¥726.08M | -CN¥653.92M | -CN¥604.68M |
| Net cash flow from continuing operations | -CN¥1.17B | -CN¥111.36M | -CN¥726.08M | -CN¥653.92M | -CN¥604.68M |
| Net Income from Continuing Operations | -CN¥1.24B | -CN¥395.26M | -CN¥932.86M | -CN¥887.17M | -CN¥832.25M |
| Gain/Loss from Continuing Operations | CN¥9.87M | -CN¥6.36M | -CN¥5.52M | -CN¥18.52M | -CN¥95.04M |
| Depreciation & Depletion & Amortization | CN¥86.48M | CN¥93.17M | CN¥93.20M | CN¥62.92M | CN¥28.33M |
| Other Non-Cash Items | CN¥82.92M | CN¥64.37M | CN¥96.06M | CN¥52.58M | CN¥34.65M |
| Change in Working Capital | -CN¥143.50M | CN¥110.97M | -CN¥9.15M | CN¥104.41M | CN¥189.65M |
| -Change in Receivables | -CN¥169.80M | CN¥62.75M | -CN¥91.54M | -CN¥388,000.00 | -CN¥53.97M |
| -Change in Inventory | -CN¥26.20M | CN¥9.57M | -CN¥6.72M | -CN¥5.52M | -CN¥3.93M |
| -Change in Prepaid Assets | -CN¥86.34M | -CN¥14.42M | -CN¥7.84M | CN¥3.12M | -CN¥17.68M |
| -Change in Payables and Accrued Expense | CN¥128.58M | CN¥98.03M | CN¥25.46M | CN¥82.15M | CN¥65.37M |
| -Change in Other Current Assets | CN¥27.78M | -CN¥48.95M | -CN¥3.55M | CN¥29.38M | CN¥15.04M |
| -Change In Other Working Capital | -CN¥17.54M | CN¥3.99M | CN¥75.04M | -CN¥4.32M | CN¥194.87M |
| Net cash flow from investing | -CN¥1.00B | -CN¥362.04M | CN¥21.92M | -CN¥384.61M | -CN¥466.52M |
| Net Cash Flow from Continuing Investing Activities | -CN¥1.00B | -CN¥362.04M | CN¥21.92M | -CN¥384.61M | -CN¥466.52M |
| Net PPE Purchase and Sale | -CN¥27.57M | -CN¥24.29M | -CN¥46.09M | -CN¥200.94M | -CN¥435.08M |
| Net Intangibles Purchase and Sale | CN¥0.00 | CN¥0.00 | -CN¥10.74M | -CN¥33.68M | -CN¥1.21M |
| Net Business Purchase and Sale | -CN¥43.34M | -CN¥25.52M | -CN¥20.00M | -CN¥20.00M | -CN¥36.20M |
| Net Investment Purchase and Sale | -CN¥929.14M | -CN¥312.23M | CN¥98.75M | -CN¥130.00M | CN¥5.97M |
| Financing Cash Flow | CN¥2.54B | CN¥314.77M | CN¥368.75M | CN¥619.27M | CN¥1.78B |
| Net Cash Flow from Continuing Financing Activities | CN¥2.54B | CN¥314.77M | CN¥368.75M | CN¥619.27M | CN¥1.78B |
| Net Issuance Payments Of Debt | CN¥307.26M | -CN¥145.34M | -CN¥13.36M | CN¥695.87M | CN¥539.50M |
| Net Common Stock Issuance | CN¥2.30B | CN¥533.94M | CN¥464.16M | -CN¥26.78M | CN¥1.17B |
| Cash Dividends Paid | CN¥0.00 | CN¥0.00 | CN¥0.00 | CN¥0.00 | CN¥0.00 |
| Proceeds from Stock Option Exercised | CN¥4,000.00 | CN¥6,000.00 | CN¥8,000.00 | CN¥19,000.00 | CN¥103.87M |
| Net Other Financing Charges | -CN¥11.73M | -CN¥13.28M | CN¥10.29M | – | -CN¥16.07M |
| Ending Cash Balance | CN¥1.20B | CN¥893.10M | CN¥1.04B | CN¥1.35B | CN¥1.71B |
| Net Change in Cash | CN¥365.92M | -CN¥158.63M | -CN¥335.40M | -CN¥419.26M | CN¥710.19M |
| Beginning Cash Balance | CN¥893.10M | CN¥1.04B | CN¥1.35B | CN¥1.71B | CN¥1.02B |
| Effect of Exchange Rate Changes | -CN¥63.24M | CN¥13.68M | CN¥27.81M | CN¥58.01M | -CN¥23.28M |
| Free Cash Flow | -CN¥1.20B | -CN¥135.65M | -CN¥782.92M | -CN¥890.88M | -CN¥1.04B |
| -Change in Other Current Liabilities | – | – | – | – | -CN¥10.06M |
No comments yet — be the first to weigh in on AAPG.
Sign in to join the discussion.